Cash flow Gufic Biosciences Limited

Equities

GUFICBIO

INE742B01025

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:00:50 2026-01-16 EST			5-day change	1st Jan Change
314.75 ^INR	-0.10%		-1.61%	-6.53%

11-17	Gufic Biosciences Limited, Q2 2026 Earnings Call, Nov 17, 2025
11-14	Gufic Biosciences posts Sept-quarter consol revenue from operations 2.37 billion rupees	RE

9b46.A8GMJE7AZrBbGXqgXL1HkR5rTkXiq0YYuJ_q1O0NUII.U-zobzeTMdZoXwDNbooOp1NaJyar8QF9_f7dpaRkZ7Juq-9iKPQWxDRuNw

Published financial data: GUFIC BIOSCIENCES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	4.88B	7.79B	6.91B	8.07B	8.2B
Total Revenues	4.88B	7.79B	6.91B	8.07B	8.2B
Cost of Goods Sold, Total	2.57B	4.21B	3.39B	3.99B	3.82B
Gross Profit	2.31B	3.58B	3.51B	4.08B	4.38B
Selling General & Admin Expenses, Total	691M	937M	940M	1.13B	1.31B
Depreciation & Amortization - (IS)	163M	171M	223M	170M	211M
Other Operating Expenses	781M	1.19B	1.2B	1.47B	1.69B
Other Operating Expenses, Total	1.64B	2.3B	2.36B	2.77B	3.2B
Operating Income	677M	1.29B	1.15B	1.31B	1.17B
Interest Expense, Total	-118M	-34.87M	-66.36M	-146M	-230M
Interest And Investment Income	14.5M	18.8M	14.12M	14.12M	15.74M
Net Interest Expenses	-103M	-16.08M	-52.23M	-132M	-215M
Currency Exchange Gains (Loss)	14.34M	6.93M	-29.61M	4.97M	-22.97M
Other Non Operating Income (Expenses)	-10.77M	-8.97M	-4.56M	-5.28M	4.46M
EBT, Excl. Unusual Items	577M	1.27B	1.07B	1.18B	940M
Impairment of Goodwill	-210K	-	-	-	-
Gain (Loss) On Sale Of Assets	374K	684K	302K	-23M	1.16M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	577M	1.27B	1.07B	1.16B	941M
Income Tax Expense	135M	310M	270M	295M	245M
Earnings From Continuing Operations	442M	958M	797M	861M	696M
Net Income to Company	442M	958M	797M	861M	696M
Minority Interest	-	-	-	-	8K
Net Income - (IS)	442M	958M	797M	861M	696M
Net Income to Common Incl Extra Items	442M	958M	797M	861M	696M
Net Income to Common Excl. Extra Items	442M	958M	797M	861M	696M
Per Share Items
Net EPS - Basic	4.56	9.89	8.22	8.74	6.95
Basic EPS - Continuing Operations	4.56	9.89	8.22	8.74	6.95
Basic Weighted Average Shares Outstanding	96.94M	96.94M	96.94M	98.52M	100M
Net EPS - Diluted	4.56	9.89	8.22	8.74	6.95
Diluted EPS - Continuing Operations	4.56	9.89	8.22	8.74	6.95
Diluted Weighted Average Shares Outstanding	96.94M	96.94M	96.94M	98.52M	100M
Normalized Basic EPS	3.72	8.17	6.88	7.48	5.86
Normalized Diluted EPS	3.72	8.17	6.88	7.48	5.86
Dividend Per Share	0.1	0.1	0.1	0.1	0.1
Payout Ratio	0.82	0.96	1.31	1.13	1.44
Supplemental Items
EBITDA	804M	1.43B	1.31B	1.41B	1.31B
EBITA	677M	1.29B	1.15B	1.31B	1.17B
EBIT	677M	1.29B	1.15B	1.31B	1.17B
EBITDAR	814M	1.47B	1.32B	1.42B	1.33B
Total Revenues (As Reported)	4.91B	7.82B	6.93B	8.09B	8.23B
Effective Tax Rate - (Ratio)	23.36	24.44	25.31	25.53	26.02
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	115M	322M	282M	284M	187M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	20.11M	-11.52M	-11.94M	31.65M	57.51M
Normalized Net Income	361M	792M	667M	737M	588M
Interest Capitalized	-	-	-	-	94.18M
Interest on Long-Term Debt	9.39M	6.26M	13.11M	20.21M	21.5M
Non-Cash Pension Expense	3.35M	3.8M	5.09M	6.31M	7.37M
Supplemental Operating Expense Items
Advertising Expense	18.57M	33.44M	59.56M	21.22M	18.63M
Selling and Marketing Expenses	18.57M	33.44M	59.56M	21.22M	18.63M
Research And Development Expense From Footnotes	20.99M	44.29M	51.86M	54.4M	56.38M
Net Rental Expense, Total	10.44M	47.05M	13.37M	14.7M	16.1M
Imputed Operating Lease Interest Expense	10.46M	20.85M	3.56M	5.13M	12.49M
Imputed Operating Lease Depreciation	-18.88K	26.2M	9.81M	9.57M	3.61M
Maintenance & Repair Expenses, Total	62.21M	87.34M	74.65M	87.31M	72.85M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	1.04M
Total Stock-Based Compensation	-	-	-	-	1.04M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	62.01M	116M	286M	11.37M	157M
Total Cash And Short Term Investments	62.01M	116M	286M	11.37M	157M
Accounts Receivable, Total	1.25B	1.52B	2.05B	3.3B	3.15B
Other Receivables	-	-	-	-	15.7M
Notes Receivable	2.53M	3.83M	2.04M	3.73M	3.22M
Total Receivables	1.25B	1.52B	2.06B	3.3B	3.16B
Inventory	944M	1.16B	1.83B	2B	2.17B
Prepaid Expenses	5.8M	8.51M	9.5M	8.61M	13.11M
Other Current Assets, Total	346M	408M	454M	677M	741M
Total Current Assets	2.61B	3.21B	4.64B	6B	6.25B
Gross Property Plant And Equipment	1.61B	2.18B	4.14B	5.47B	6.28B
Accumulated Depreciation	-482M	-621M	-859M	-862M	-1.06B
Net Property Plant And Equipment	1.13B	1.55B	3.28B	4.6B	5.21B
Long-term Investments	75K	75K	7.84M	17.84M	17.84M
Goodwill	0	0	0	-	-
Other Intangibles, Total	4.45M	6.1M	6.79M	56.19M	63.44M
Accounts Receivable Long-Term	-	-	-	-	-
Loans Receivable Long-Term	116M	2.41M	3.41M	4.14M	2.16M
Deferred Tax Assets Long-Term	-	-	9.66M	-	-
Other Long-Term Assets, Total	65.13M	444M	658M	239M	150M
Total Assets	3.92B	5.21B	8.61B	10.93B	11.69B
Liabilities
Accounts Payable, Total	1.13B	1.41B	1.3B	1.66B	1.59B
Accrued Expenses, Total	192M	172M	144M	184M	197M
Short-term Borrowings	163M	65.99M	1.12B	-	1.54B
Current Portion of Long-Term Debt	35.98M	72.46M	89.67M	1.63B	256M
Current Portion of Leases	33.66M	28.16M	65.76M	43.26M	62.27M
Current Income Taxes Payable	15.82M	6.75M	31.24M	25.45M	-
Unearned Revenue Current, Total	28.27M	-	-	-	-
Other Current Liabilities	37.38M	115M	131M	174M	230M
Total Current Liabilities	1.64B	1.87B	2.88B	3.72B	3.88B
Long-Term Debt	354M	474M	1.91B	1.54B	1.3B
Long-Term Leases	28.22M	3.29M	162M	116M	196M
Pension & Other Post Retirement Benefits	51.34M	65.88M	77.74M	90.59M	105M
Deferred Tax Liability Non Current	14.9M	1.9M	-	20.63M	77.72M
Other Non Current Liabilities	101M	108M	105M	113M	123M
Total Liabilities	2.19B	2.52B	5.13B	5.6B	5.68B
Common Stock, Total	96.94M	96.94M	96.94M	100M	100M
Additional Paid In Capital	-	-	-	997M	997M
Retained Earnings	950M	1.9B	2.69B	3.54B	4.22B
Comprehensive Income and Other	687M	695M	695M	691M	690M
Total Common Equity	1.73B	2.69B	3.48B	5.33B	6.01B
Total Equity	1.73B	2.69B	3.48B	5.33B	6.01B
Total Liabilities And Equity	3.92B	5.21B	8.61B	10.93B	11.69B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	96.94M	96.94M	96.94M	100M	100M
ECS Total Common Shares Outstanding	96.94M	96.94M	96.94M	100M	100M
Book Value / Share	17.89	27.76	35.88	53.11	59.94
Tangible Book Value	1.73B	2.69B	3.47B	5.27B	5.95B
Tangible Book Value Per Share	17.84	27.7	35.81	52.55	59.31
Total Debt	615M	644M	3.34B	3.33B	3.36B
Net Debt	553M	528M	3.06B	3.32B	3.2B
Debt Equivalent of Unfunded Proj. Benefit Obligation	55.32M	69.76M	84.27M	102M	113M
Debt Equivalent Oper. Leases	83.55M	376M	107M	118M	129M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	426M	447M	792M	968M	883M
Inventories - Work In Process, Total	282M	205M	574M	553M	755M
Inventories - Finished Goods, Total	236M	505M	468M	484M	531M
Land - (BS)	-	63.05M	-	98.9M	104M
Buildings, Total	235M	356M	418M	384M	1.23B
Machinery, Total	1.12B	1.23B	1.53B	1.52B	4.17B
Full Time Employees	1.25K	1.38K	1.63K	1.49K	1.48K
Accumulated Allowance for Doubtful Accounts (Supple)	30.37M	44.4M	43.79M	55.86M	71.16M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	442M	958M	797M	861M	696M
Depreciation & Amortization - CF	162M	170M	220M	167M	205M
Amortization of Goodwill and Intangible Assets - (CF)	766K	766K	722K	635K	530K
Depreciation & Amortization, Total	163M	171M	221M	168M	205M
Amortization of Deferred Charges, Total - (CF)	144K	408K	1.78M	2.61M	5.31M
(Gain) Loss From Sale Of Asset	374K	-684K	-303K	23M	-1.16M
Asset Writedown & Restructuring Costs	210K	-	-	-	-
Stock-Based Compensation (CF)	-	-	-	-	1.04M
Other Operating Activities, Total	185M	17.4M	67.1M	173M	244M
Change In Accounts Receivable	-190M	-232M	-553M	-1.53B	73.66M
Change In Inventories	281M	-212M	-679M	-170M	-164M
Change In Accounts Payable	9.02M	342M	-120M	400M	165M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	891M	1.04B	-266M	-74.57M	1.23B
Capital Expenditure	-142M	-888M	-1.88B	-1.13B	-755M
Sale of Property, Plant, and Equipment	-	684K	316K	45.66M	47.67M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-7.77M	-10M	-
Other Investing Activities, Total	57.06M	-72.04M	-23.81M	67.39M	-187K
Cash from Investing	-85.07M	-959M	-1.91B	-1.02B	-708M
Short Term Debt Issued, Total	-	-	1.43B	423M	168M
Long-Term Debt Issued, Total	154M	120M	1.07B	-	-
Total Debt Issued	154M	120M	2.5B	423M	168M
Short Term Debt Repaid, Total	-768M	-60.78M	-	-	-
Long-Term Debt Repaid, Total	-34.44M	-30.43M	-66.19M	-437M	-321M
Total Debt Repaid	-802M	-91.21M	-66.19M	-437M	-321M
Issuance of Common Stock	-	-	-	1B	-
Common Dividends Paid	-3.63M	-9.21M	-10.44M	-9.72M	-10.03M
Common & Preferred Stock Dividends Paid	-3.63M	-9.21M	-10.44M	-9.72M	-10.03M
Other Financing Activities, Total	-134M	-50.29M	-81.22M	-152M	-209M
Cash from Financing	-786M	-31M	2.34B	824M	-372M
Miscellaneous Cash Flow Adjustments	1K	-	-	-1K	-
Net Change in Cash	19.4M	54.07M	170M	-275M	146M
Supplemental Items
Cash Interest Paid	134M	48.09M	79.06M	147M	209M
Cash Income Tax Paid (Refund)	94.03M	331M	277M	270M	228M
Levered Free Cash Flow	529M	-183M	-2.33B	-1.43B	-80.69M
Unlevered Free Cash Flow	602M	-161M	-2.29B	-1.34B	63.24M
Change In Net Working Capital	-159M	248M	1.36B	1.2B	127M
Net Debt Issued / Repaid	-648M	28.5M	2.43B	-13.98M	-153M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.58	17.6	10.43	8.39	6.48
Return on Total Capital	17.23	28.27	14.2	10.59	8.14
Return On Equity %	29.22	43.31	25.84	19.57	12.29
Return on Common Equity	29.22	43.31	25.84	19.57	12.29
Margin Analysis
Gross Profit Margin %	47.4	46.01	50.87	50.58	53.41
SG&A Margin	14.17	12.02	13.61	14.04	15.94
EBITDA Margin %	16.48	18.29	18.92	17.45	15.98
EBITA Margin %	13.89	16.51	16.71	16.27	14.32
EBIT Margin %	13.87	16.5	16.7	16.26	14.31
Income From Continuing Operations Margin %	9.07	12.3	11.54	10.68	8.5
Net Income Margin %	9.07	12.3	11.54	10.68	8.5
Net Avail. For Common Margin %	9.07	12.3	11.54	10.68	8.5
Normalized Net Income Margin	7.39	10.17	9.66	9.14	7.17
Levered Free Cash Flow Margin	10.85	-2.35	-33.76	-17.71	-0.98
Unlevered Free Cash Flow Margin	12.35	-2.07	-33.16	-16.59	0.77
Asset Turnover
Asset Turnover	1.22	1.71	1	0.83	0.72
Fixed Assets Turnover	4.32	5.81	2.85	2.05	1.67
Receivables Turnover (Average Receivables)	4.21	5.64	3.87	3.01	2.54
Inventory Turnover (Average Inventory)	2.37	4.01	2.27	2.08	1.83
Short Term Liquidity
Current Ratio	1.59	1.72	1.61	1.61	1.61
Quick Ratio	0.8	0.87	0.81	0.89	0.86
Operating Cash Flow to Current Liabilities	0.54	0.56	-0.09	-0.02	0.32
Days Sales Outstanding (Average Receivables)	86.62	64.66	94.34	121.46	143.48
Days Outstanding Inventory (Average Inventory)	154.29	91.09	160.84	176.26	199.4
Average Days Payable Outstanding	183.81	104.15	121.56	130.56	148.89
Cash Conversion Cycle (Average Days)	57.1	51.59	133.63	167.16	193.98
Long Term Solvency
Total Debt/Equity	35.48	23.93	96.09	62.51	55.93
Total Debt / Total Capital	26.19	19.31	49	38.47	35.87
LT Debt/Equity	22.05	17.73	59.48	31.08	24.97
Long-Term Debt / Total Capital	16.28	14.31	30.34	19.12	16.01
Total Liabilities / Total Assets	55.76	48.39	59.61	51.25	48.6
EBIT / Interest Expense	5.75	36.87	17.38	9.01	5.1
EBITDA / Interest Expense	7.13	41.77	20.71	10.16	5.99
(EBITDA - Capex) / Interest Expense	5.93	16.31	-7.56	2.42	2.71
Total Debt / EBITDA	0.73	0.44	2.43	2.25	2.44
Net Debt / EBITDA	0.66	0.36	2.22	2.24	2.32
Total Debt / (EBITDA - Capex)	0.88	1.13	-6.66	9.45	5.39
Net Debt / (EBITDA - Capex)	0.79	0.93	-6.09	9.42	5.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	28.74	59.76	-11.36	16.8	1.63
Gross Profit, 1 Yr. Growth %	19.29	55.05	-1.99	16.14	7.3
EBITDA, 1 Yr. Growth %	62.7	77.29	-8.64	7.74	-7.9
EBITA, 1 Yr. Growth %	75.45	89.96	-10.66	13.7	-11.5
EBIT, 1 Yr. Growth %	75.54	90.06	-10.67	13.72	-11.5
Earnings From Cont. Operations, 1 Yr. Growth %	94.96	116.68	-16.84	8.07	-19.14
Net Income, 1 Yr. Growth %	94.96	116.68	-16.84	8.07	-19.14
Normalized Net Income, 1 Yr. Growth %	91.64	119.72	-15.84	10.57	-20.3
Diluted EPS Before Extra, 1 Yr. Growth %	56.43	116.8	-16.85	6.33	-20.53
Accounts Receivable, 1 Yr. Growth %	16.39	21.73	35.57	60.58	-4.65
Inventory, 1 Yr. Growth %	-22.91	22.42	58.75	9.28	8.17
Net Property, Plant and Equip., 1 Yr. Growth %	0.26	37.64	111.33	40.14	13.28
Total Assets, 1 Yr. Growth %	-3.79	32.99	65.16	26.87	7.03
Tangible Book Value, 1 Yr. Growth %	34.35	55.21	29.28	51.8	12.86
Common Equity, 1 Yr. Growth %	34.11	55.17	29.24	53.12	12.87
Cash From Operations, 1 Yr. Growth %	89.09	19.71	-125.03	-71.95	-1.74K
Capital Expenditures, 1 Yr. Growth %	-64.33	616.18	114.52	-39.93	-32.98
Levered Free Cash Flow, 1 Yr. Growth %	-592.48	-133.45	1.44K	-38.71	-94.32
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.24K	-125.98	1.71K	-41.58	-104.76
Dividend Per Share, 1 Yr. Growth %	100	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.91	43.41	19	1.75	8.95
Gross Profit, 2 Yr. CAGR %	17.11	36	23.28	6.69	11.63
EBITDA, 2 Yr. CAGR %	32.28	69.84	27.5	-0.79	0.12
EBITA, 2 Yr. CAGR %	27.92	82.56	30.53	0.79	0.86
EBIT, 2 Yr. CAGR %	27.92	82.66	30.57	0.79	0.86
Earnings From Cont. Operations, 2 Yr. CAGR %	41.98	105.53	34.24	-5.2	-6.52
Net Income, 2 Yr. CAGR %	41.98	105.53	34.24	-5.2	-6.52
Normalized Net Income, 2 Yr. CAGR %	27.84	105.2	35.99	-3.53	-6.12
Diluted EPS Before Extra, 2 Yr. CAGR %	27.18	84.16	34.26	-5.98	-8.08
Accounts Receivable, 2 Yr. CAGR %	9.85	19.03	28.46	47.55	23.74
Inventory, 2 Yr. CAGR %	0.06	-2.86	39.4	31.71	8.73
Net Property, Plant and Equip., 2 Yr. CAGR %	83.03	17.47	70.55	72.09	26
Total Assets, 2 Yr. CAGR %	18.43	13.11	48.21	44.75	16.53
Tangible Book Value, 2 Yr. CAGR %	51.89	44.4	41.66	40.09	30.89
Common Equity, 2 Yr. CAGR %	51.72	44.26	41.61	40.67	31.46
Cash From Operations, 2 Yr. CAGR %	313.56	48.91	-44.8	-73.51	114.71
Capital Expenditures, 2 Yr. CAGR %	4.23	49.28	288.97	13.52	-36.55
Levered Free Cash Flow, 2 Yr. CAGR %	60.39	30.54	106.44	207.03	-81.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	105.3	139.25	92.09	225.16	-83.38
Dividend Per Share, 2 Yr. CAGR %	41.42	41.42	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.86	30.48	22.16	18.26	1.71
Gross Profit, 3 Yr. CAGR %	13.45	28.6	21.93	20.85	6.89
EBITDA, 3 Yr. CAGR %	27.52	45.84	38.29	20.54	-2.89
EBITA, 3 Yr. CAGR %	25.27	45.94	44.05	24.66	-3.14
EBIT, 3 Yr. CAGR %	25.3	45.97	44.1	24.69	-3.14
Earnings From Cont. Operations, 3 Yr. CAGR %	38.98	63.47	52.02	24.88	-10.09
Net Income, 3 Yr. CAGR %	38.98	63.47	52.02	24.88	-10.09
Normalized Net Income, 3 Yr. CAGR %	26.69	53.13	52.46	26.92	-9.48
Diluted EPS Before Extra, 3 Yr. CAGR %	29.15	51.93	41.28	24.22	-11.1
Accounts Receivable, 3 Yr. CAGR %	15.5	13.67	24.31	38.38	27.57
Inventory, 3 Yr. CAGR %	0.07	7.02	14.42	28.54	23.34
Net Property, Plant and Equip., 3 Yr. CAGR %	66.57	66.44	42.87	59.74	49.7
Total Assets, 3 Yr. CAGR %	18.1	23.1	28.33	40.72	30.9
Tangible Book Value, 3 Yr. CAGR %	47.72	52.99	39.18	44.96	30.35
Common Equity, 3 Yr. CAGR %	47.42	52.86	39.07	45.35	30.72
Cash From Operations, 3 Yr. CAGR %	164.38	171.7	-17.36	-55.95	4.88
Capital Expenditures, 3 Yr. CAGR %	20.58	89.33	67.6	108.69	-4.77
Levered Free Cash Flow, 3 Yr. CAGR %	32.31	-3.81	178.96	37.72	-18.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	51.21	4.09	333.23	29.18	-20.64
Dividend Per Share, 3 Yr. CAGR %	25.99	25.99	25.99	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.25	25.98	17.71	18.12	16.69
Gross Profit, 5 Yr. CAGR %	18.2	23.76	17.28	19.34	17.7
EBITDA, 5 Yr. CAGR %	31.82	44.08	27.51	25.1	21.53
EBITA, 5 Yr. CAGR %	32.76	46.18	27.35	25.95	24.91
EBIT, 5 Yr. CAGR %	32.75	46.17	27.38	25.97	24.94
Earnings From Cont. Operations, 5 Yr. CAGR %	43.28	60.42	37.06	31.46	25.15
Net Income, 5 Yr. CAGR %	43.28	60.42	37.06	31.46	25.15
Normalized Net Income, 5 Yr. CAGR %	41.14	54.57	30.33	27.29	25.58
Diluted EPS Before Extra, 5 Yr. CAGR %	36.94	53.34	31.17	25.4	18.96
Accounts Receivable, 5 Yr. CAGR %	17.23	23.8	20.52	26.17	24.08
Inventory, 5 Yr. CAGR %	13.44	12.9	14.26	16.29	12.11
Net Property, Plant and Equip., 5 Yr. CAGR %	38.54	47.86	68.15	68.68	35.87
Total Assets, 5 Yr. CAGR %	20.83	23.92	29.33	31.34	23.47
Tangible Book Value, 5 Yr. CAGR %	38.51	48.39	45.26	47.69	35.8
Common Equity, 5 Yr. CAGR %	38.56	48.45	45.07	47.86	35.97
Cash From Operations, 5 Yr. CAGR %	83.19	90.81	40.71	7.45	21.08
Capital Expenditures, 5 Yr. CAGR %	71.05	84.54	87.44	53.83	13.64
Levered Free Cash Flow, 5 Yr. CAGR %	33.35	13.42	59.15	47.37	-5.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	47.2	22.41	67.39	56.41	17.56
Dividend Per Share, 5 Yr. CAGR %	14.87	14.87	14.87	14.87	14.87